Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Biochemical Pharmacology
|
July 14, 2005
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
Sigrid Hatse, Katrien Princen, Erik De Clercq, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker
G J Bridger, R T Skerlj, D Thornton, et al.
Bioconjugate Chemistry
|
March 1, 1996
A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments
G J Bridger, M J Abrams, S Padmanabhan, et al.
Blood
|
July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
W Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.
Biochemistry
|
January 30, 1996
Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues
C K Derian, H F Solomon, J D Higgins, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor
J D Higgins, G J Bridger, C K Derian, et al.
Antiviral Research
|
March 1, 1996
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding
K De Vreese, D Reymen, P Griffin, et al.
Bioconjugate Chemistry
|
September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging
D S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1997
Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates
M E Ultee, G J Bridger, M J Abrams, et al.
Supportive Cancer Therapy
|
July 17, 2008
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist
Kai Hübel, W Conrad Liles, Hal E Broxmeyer, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Biochemical Pharmacology
|
July 14, 2005
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
Sigrid Hatse, Katrien Princen, Erik De Clercq, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker
G J Bridger, R T Skerlj, D Thornton, et al.
Bioconjugate Chemistry
|
March 1, 1996
A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments
G J Bridger, M J Abrams, S Padmanabhan, et al.
Blood
|
July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
W Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.
Biochemistry
|
January 30, 1996
Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues
C K Derian, H F Solomon, J D Higgins, et al.
Journal of Medicinal Chemistry
|
March 1, 1996
N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor
J D Higgins, G J Bridger, C K Derian, et al.
Antiviral Research
|
March 1, 1996
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding
K De Vreese, D Reymen, P Griffin, et al.
Bioconjugate Chemistry
|
September 30, 1999
RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging
D S Edwards, S Liu, M C Ziegler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 1997
Tumor imaging with technetium-99m-labeled hydrazinonicotinamide-Fab' conjugates
M E Ultee, G J Bridger, M J Abrams, et al.
Supportive Cancer Therapy
|
July 17, 2008
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 Antagonist
Kai Hübel, W Conrad Liles, Hal E Broxmeyer, et al.
Page
of 7